Sonic hedgehog (Shh) has been reported to act as a mitogen and survival factor for muscle satellite cells. However, its role in their differentiation remains ambiguous. Here, we provide evidence that Shh promotes the proliferation and differentiation of primary cultures of chicken adult myoblasts (also termed satellite cells) and mouse myogenic C2 cells. These effects are reversed by cyclopamine, a specific chemical inhibitor of the Shh pathway. In addition, we show that Shh and its downstream molecules are expressed in adult myoblast cultures and localize adjacent to Pax7 in muscle sections. These gene expressions are regulated during postnatal muscle growth in chicks. Most importantly, we report that Shh induces MAPK/ERK and phosphoinositide 3-kinase (PI3K)-dependent Akt phosphorylation and that activation of both signaling pathways is essential for Shh's signaling in muscle cells. However, the effect of Shh on Akt phosphorylation is more robust than that on MAPK/ERK, and data suggest that Shh influences these pathways in a manner similar to IGF-I. By exploiting specific chemical inhibitors of the MAPK/ERK and PI3K/Akt signaling pathways, UO126 and Ly294002, respectively, we demonstrate that Shh-induced Akt phosphorylation, but not that of MAPK/ERK, is required for its promotive effects on muscle cell proliferation and differentiation. Taken together, we suggest that Shh acts in an autocrinic manner in adult myoblasts, and provide first evidence of a role for PI3K/Akt in Shh signaling during myoblast differentiation.
Introduction
The ability of adult muscle tissue to grow or regenerate in response to injury is dependent on the activation and proliferation of satellite cells (also termed adult myoblasts). These small mononucleated cells lie under the basal lamina of the myofiber and are present in the muscle mostly in their quiescent state [1] . Nevertheless, during growth or upon muscle injury, satellite cells become mitotically active, displaying programmed proliferation and differentiation followed by expression of muscle-specific proteins [2, 3] . These processes are tightly regulated by the muscle-specific helix-loop-helix MyoD family of proteins, MyoD, myogenin, Myf5 and MRF4, and the myocyte enhancerbinding factor 2 (MEF2) [4] . The pair-box transcription factor Pax7 is specifically expressed in quiescent satellite cells and has been shown to be co-expressed with MyoD during cell proliferation and to decline when cells undergo differentiation [5, 6] .
Several growth factors have been implicated in stimulating or inhibiting satellite-cell proliferation and differentiation. Among these factors are members of the fibroblast growth factor family, insulin-like growth factor I and II (IGF-I and II), transforming growth factor beta, platelet-derived growth factor and hepatocyte growth factor (HGF) [3, 7] . HGF has been shown to act as an activator and a powerful mitogen for satellite cells via the mitogen-activated protein kinase/extracellular signal-regulated protein kinase (MAPK/ERK) pathway [8] [9] [10] . Conversely, IGF-I, although serving as a mitogen, has been reported to be more effective in inducing cell differentiation and hypertrophy via the phosphoinositide 3′-kinase (PI3K)/Akt pathway [11] [12] [13] [14] [15] .
Recent reports have suggested that the embryonic factor sonic hedgehog (Shh) plays a role in satellite cell proliferation and differentiation [16, 17] . In the embryo, Shh is expressed in the notochord and neural floor plate and upregulates the formation and survival of the dorsal myotome muscle cell lineages [18] [19] [20] [21] [22] . Furthermore, Shh has been shown to stimulate the proliferation and subsequent differentiation of already committed myoblasts in the limb bud [23] .
The intracellular mechanisms that mediate the actions of Shh on target cells are only partially understood. Shh binding to its receptor Patched (Ptch) relieves Ptch inhibition of an adjacent Gprotein-coupled membrane protein, smoothened (Smo). Once activated, Smo induces a complex series of intracellular reactions that activate the Gli (glioma-associated oncogene) protein(s) Gli-1, Gli-2 or Gli-3, for translocation to the nucleus and regulation of target gene transcription, such as Ptch1, Gli, and Wnt [24] [25] [26] [27] .
Shh and Ptch1 have been shown to be upregulated in regenerating muscle following ischemia, suggesting that the embryonic Shh pathway can be recapitulated in adults [28] . Further studies in mammals have reported the inductive effects of Shh on satellite cell proliferation; however, its role in satellite cell differentiation remains controversial: whereas some studies show a direct effect of Shh on the induction of muscle cell differentiation [16] , others have reported its inhibitory effect [17] . The present study was aimed at studying regulation of the Shh pathway in myoblasts during the early growth phase in posthatch chicks, as well as the role of Shh in the proliferation and differentiation of muscle cells. We show that in primary cultures of adult myoblasts derived from chicks at various days of age, Shh, Ptch1 and Gli mRNA levels are upregulated in parallel to the onset of myoblast differentiation. We found that Shh induces both the proliferation and differentiation of primary cultures of chicken myoblasts as well as of a mouse myogenic cell line. We report here that whereas both MAPK/ ERK and PI3K/Akt signaling pathways are essential for Shh's actions in muscle cells, the PI3K/Akt but not MAPK/ERK pathway is directly involved in adult muscle cell proliferation and differentiation.
Materials and methods

Reagents
Dulbecco's Modified Eagle's Medium (DMEM), sera and antibioticantimycotic solution were purchased from Biological Industries. UO126, Ly294002, Wortmannin and urokinase (uPA) were obtained from Calbiochem. Human recombinant pre-HGF and IGF-I were purchased from R&D Systems. Mouse recombinant N-terminus active Shh (N-Shh) was prepared according to a protocol kindly provided by David Bumcrot and Andrew McMahon (Harvard University, Cambridge, MA). For further details see Bumcrot et al. [29] .
Cell cultures
C2 mouse myogenic cells [30] were grown in DMEM supplemented with 20% (v/v) fetal bovine serum (FBS). For the experiments, cells were plated sparsely at 3 × 10 5 cells/100 mm Petri dish in growing medium for 1 day, after which the medium was changed to serum-free DMEM and cells were incubated for an additional 48 h. For experiments with HGF, pre-HGF was activated by overnight cleavage with uPA (5.5 U/ng HGF) in 50 mM Tris-HCl buffer pH 8.8 containing 0.01% (v/v) Tween 20 at 37°C [11] .
Chicken skeletal muscle satellite cells were cultured from the pectoralis muscle of 3-day-old chicks as described by Halevy and Lerman [31] . Cells were plated at 5 × 10 4 cells/cm 2 in DMEM supplemented with 10% (v/v) horse serum (HS), and grown in culture. Cells were induced to differentiate in 2% HS. In some experiments, freshly prepared cells were incubated for 1 day, and then were rendered quiescent in serum-free DMEM for 40 h prior to treatment.
Muscle sampling for mRNA analysis and histology
Chick muscle samples were excised from the superficial regions of the proximal one half of the left pectoralis major of each chick as previously described [32] . Mouse (C57BL/6J strain) hindlimb muscle samples (Gastrocnemius) were excised from 7-week-old mice.
RNA preparation and RT-PCR
Total RNAwas prepared using TRIzol™ Reagent (Invitrogen) and quantified by spectrophotometric absorbance at 260 nm. Total RNA (1 μg) was reversetranscribed into cDNA using random primers and SuperScript reverse transcriptase (Invitrogen). Polymerase chain reaction (PCR) was then performed using Taq DNA polymerase (Fermentas) for each set of specific primers. Primer sets and reaction conditions are summarized in Table 1 . Either 18S or GAPDH were used as internal controls to normalize the sample mRNA amounts. PCR products were separated by electrophoresis and bands were visualized by video camera (Dinco-Ranium). In addition, the identity of the corresponding genes was verified by sequencing the PCR products.
Immunohistochemistry
Mouse muscle samples were fixed in fresh 4% (v/v) paraformaldehyde in PBS solution (pH 7.4) for 24 h and embedded in paraffin and deparaffinized as previously described [6] . Immunohistochemistry was performed as described in Halevy et al. [6] with primary antibodies for Shh (1: 50) and Ptch1 (1: 50, Santa Cruz), anti-Pax7 (1:2, Developmental Studies Hybridoma Bank, University of Iowa, IA), and anti-laminin (1: 700, Sigma). Secondary antibodies were rhodamine-conjugated donkey anti-goat IgG (1: 250, Jackson), Alexa Fluor 488 goat anti-rabbit IgG or Alexa Fluor 594 goat anti-rabbit (1:250, Molecular Probes). Nuclei were detected with 4′6′-diamino-2-phenylindole (DAPI, 1 μg/ml). Sections were mounted in Vectashield (Vector Laboratories). 
Western blot analysis
Western blot and densitometric analyses were performed as described in [6] . Equal amounts of protein from muscle extracts were separated by SDS-PAGE and transferred to nitrocellulose filters (Biorad). Membranes were incubated overnight at 4°C with the appropriate antibodies, then washed and incubated for 1 h with horseradish peroxidase-conjugated goat anti-mouse or goat anti-rabbit IgG (Zymed). The following primary antibodies were used: anti-phospho-MAPK/ERK and anti-phospho-Akt antibodies, anti-total MAPK/ERK and Akt polyclonal antibodies (Cell Signaling), anti-MEF2, anti-Ptch1 and anti-Smo polyclonal antibodies and monoclonal anti-myogenin (Santa Cruz), monoclonal anti-myosin heavy chain (MHC; MF20) and monoclonal anti-Pax7 (Hybridoma Bank), and polyclonal anti-p21 and monoclonal anti-p27 and anti-pRb antibodies (BD Pharmingen) and monoclonal anti-α Tubulin antibody (Oncogene).
Results
The Shh pathway is regulated in muscle during the early phase of postnatal growth
The regulation of Shh-cascade gene expression during muscle development was analyzed in primary cultures of myoblasts prepared from pectoralis muscles of pre-and posthatch chicks. In late-term chick embryos, the muscle cell population consists of fetal and adult myoblasts, whereas after hatch, only adult myoblasts (satellite cells) are found [33, 34] . Cells derived from muscles at various days of age were cultured for 1 day, then harvested and the expression levels of MyoD, Shh, Ptch1, Smo and Gli mRNA were analyzed by RT-PCR (Fig. 1A) . MyoD gene expression decreased towards hatch, then increased until day 4 posthatch and declined on day 5, indicating, as previously shown, high proliferative activity followed by differentiation of adult myoblasts in chick muscle on these days [35, 36] . Shh, Ptch1, and Gli mRNAs were expressed on all days, with a decrease in their expression levels towards the end of the embryonic period and an increase in levels from day 1; the Shh increase preceding that of Gli and Ptch1, decreasing on day 5 (Fig. 1A) . Smo expression remained relatively constant throughout. The regulation of the Shh pathway was analyzed during the proliferation and differentiation of primary cultures of muscle cells derived from 3-day-old chick pectoralis muscle. In these cultures, prepared with an extensively-used protocol [6, 10, 31] , over 95% of the mononucleated cells express Pax7 [6] , recently shown to be a marker for satellite cells [5] . All genes except MHC were expressed in freshly prepared cells (day 0; Fig. 1B ). Shh mRNA levels increased in the proliferating cells on day 1 and those of Ptch1 and Gli1 peaked the following day and then declined slightly in myotubes. Shh levels decreased somewhat on day 2 and increased again in the differentiated cells. Smo mRNA levels remained comparable in both proliferating cells and myotubes, consistent with the results shown in Fig. 1A . The proliferative state of the cells was indicated by Pax7 mRNA expression levels: these were highest on day 0 and during the first 2 days in culture, then declined when cells were switched to low-serum conditions to differentiate and express high levels of MHC [6] . Fig. 1C demonstrates that the kinetics of MyoD, Shh and Ptch1 mRNA expression in pectoralis muscle tissue derived from pre-and posthatch chicks is similar to that in myoblasts (see Fig. 1A ). The upregulation in Shh mRNA expression levels in muscle on day 3 of age was more pronounced than that in the muscle cell cultures.
Along the same lines, Ptch1 protein expression was observed in hindlimb muscle sections of 7-week-old mice and this expression co-localized with that of laminin ( Figs. 2A and B) ; the latter is typically expressed in the basement membrane surrounding the muscle fibers. Shh protein expression corresponded to that of Ptch1 and co-localized with or adjacent to the nuclei under the basal lamina (Fig. 2C) . These nuclei appear to be satellite cells as indicated by Pax7 expression which corresponded with that of Shh (Figs. 2D-F) . This is emphasized in a higher magnification where Shh staining surrounds that of Pax7 (Fig. 2G) .
Addition of recombinant Shh (N-Shh) to primary cultures of chick muscle cells, which had been rendered quiescent for 40 h in serum-free medium, induced Ptch1 and Smo mRNA expression at Shh concentrations as low as 0.5 μg/ml (Fig.  3A) . Due to a lack of antibodies recognizing chicken Ptch1 and Smo, the analysis at the protein expression level was conducted in the mouse myogenic cell line C2 [30] . Addition of N-Shh to serum-starved cells at various concentrations induced protein expression levels of both Ptch1 and Smo in a dose-responsive manner (Fig. 3B) , suggesting that Shh-induced gene expression is also regulated at the post-transcriptional level in muscle cells.
Shh promotes the proliferation and differentiation of adult myoblasts
Shh has been shown to induce myoblast proliferation and differentiation during limb development of chick embryos [23] . To examine Shh's potential effects on these processes in adult myoblasts, we took advantage of both chick primary muscle cultures and the mouse C2 cell line. Cells were rendered quiescent for 40 to 48 h, resulting in a marked decline in the expression levels of myogenic factors (e.g., MyoD, data not shown). In primary cultures of chicken myoblasts, addition of NShh at various concentrations for an additional 24 h enhanced the mRNA-expression levels of Pax7, an early marker for muscle cell proliferation [5, 6] , and MyoD, in a bell-shaped manner (Fig.  4A) . These changes were more profound at the protein level of Pax7 (Fig. 4B) . Similarly, increased levels of thymidine incorporation into DNA the chicken muscle cells were observed in response to N-Shh (data not shown). In C2 cells, Pax7 protein levels were induced in response to Shh in a bell-shape manner (Fig. 4C, see also Fig. 4D ). It should be noted that the difference in overall Pax7 protein levels between chicken and C2 cells is probably technical as the antibody against Pax7 was raised against the chicken type.
The promotive effect of Shh on cell differentiation was demonstrated by the upregulation of MHC mRNA myogenin (Fig. 4A) and of MEF2 and MHC protein levels in the chicken cells (Fig. 4B) . Likewise, levels of cell cycle inhibitory proteins, known to be upregulated during muscle cell differentiation [37] [38] [39] [40] , were upregulated by N-Shh; p21 and p27 in chick myoblasts (Fig. 4B ) and p27 and pRb in C2 myoblasts (Fig. 4C ). Pax7 and MHC protein expression was markedly reduced in C2 cells by cyclopamine, a specific inhibitor of Smo and hence an inhibitor of Shh signaling (Fig. 4D ) [41] , suggesting a specific action of Shh in inducing muscle cell proliferation and differentiation. Moreover, these pathways have been shown to be essential for Shh signaling in neural cells and chondrocytes [42, 43] . We tested whether these pathways play a role in Shh signaling in adult myoblast proliferation and differentiation. Phosphorylation of Akt at 473 Ser, using a phospho-specific antibody, provides a convenient marker for the extent of activation of the PI3K pathway in vivo. N-Shh induced phosphorylation of Akt in a dose-response manner in primary cultures of chicken myoblasts and in the C2 cell line (Figs. 5A, C) , and administration of the PI3K inhibitor, Wortmannin, abolished this effect (Fig. 5C ), in agreement with previous studies [43, 44] . Similarly, N-Shh induced the phosphorylation of MAPK/ERK in both cell types and this was inhibited by the MEK-specific inhibitor UO126 (Figs. 5A, C, see also Fig. 6A) . A time-course experiment revealed that MAPK/ERK phosphorylation is induced within 12 min. However, whereas its phosphorylation remained high in the chick myoblasts up to 40 min (Fig. 5B) , this effect was very transient in C2 cells and the phosphorylation levels were substantially reduced after 20 min (Fig. 5D ). Akt phosphorylation was highly induced within 12 min of incubation with Shh (1 μg/ml) in both chick myoblasts and mouse C2 cells (Figs. 5B, D) , and these phosphorylation levels remained high, even after 120 min.
Reports on the direct effects of Shh on MAPK and PI3K pathways are controversial. Whereas some indicate a direct effect [43, 44] , others provide evidence of Shh's indirect cooperation with these signaling pathways [42, 45] . Here, addition of cyclopamine (1 μM), a specific inhibitor of Smo [41] , to serum-starved C2 cells in the presence of N-Shh inhibited the Shh-induced MAPK/ERK and Akt phosphorylation (Fig. 6A) . Expression levels of Shh target gene, Ptch1, were reduced in these cells in the presence of specific inhibitors of the MAPK/ ERK and PI3K/Akt pathways, UO126 and Ly294002, respectively (Fig. 6B) , suggesting that the Shh-induced effect on these pathways is Smo-mediated.
We compared the effect of Shh on MAPK/ERK and Akt phosphorylation in C2 cells vs. a human prostate cancer cell line, PC3, known to respond to Shh [46] . As was shown in Figs. 5C, D, N-Shh induces MAPK/ERK and Akt phosphorylation and this is inhibited by their specific inhibitors, UO126 and Wortmannin, respectively (Fig. 6C, left panel) . In contrast, NShh did not have any inductive effect on the phosphorylation of these signaling molecules in PC3 cells (Fig. 6C, right panel) , suggesting that the effect of Shh on these signaling pathways is cell-type specific.
Shh influences the MAPK/ERK and PI3K/Akt pathways in a manner similar to IGF-I
Because Shh induced both MAPK/ERK and Akt phosphorylation in muscle cells, we examined how Shh's effects relate to those of other growth factors known to affect these pathways in these cells. We performed a side-by-side comparison of the abilities of Shh, HGF and IGF-I to activate these pathways in C2 myogenic cells; the latter two growth factors have been reported to affect the MAPK/ERK and PI3K/Akt pathways [9, 10, 12] in opposite ways [11] . A time-course experiment, using concentrations that have been shown to be optimal for growth-factor activity [11] , clearly demonstrated substantially higher MAPK/ ERK phosphorylation levels in response to HGF relative to those in response to IGF-I and Shh (Fig. 7A) . Although the phosphorylation was highly transient in all cases, it lasted longer in the case of HGF than in that of IGF-I or Shh.
An increase in Akt phosphorylation could be detected in response to all factors within 5 min of incubation, with the response to IGF-I being markedly higher than that to Shh or HGF. However, in contrast to the case of HGF in which the Akt phosphorylation signal was highly transient, this signal persisted for a longer period, up to 40 min, in response to both Shh and IGF-I (Fig. 7B , see also Figs. 5B and D). Taken together, these results suggest that Shh affects the MAPK/ERK and PI3K/Akt pathways in a manner similar to IGF-I, albeit to a lesser extent.
Next, we asked whether Shh-induced MAPK/ERK and Akt phosphorylation is required for its inductive effects on muscle cell proliferation and differentiation. To that end, specific inhibitors for the MAPK/ERK and PI3K/Akt signaling pathways, UO126 and Ly294002, respectively, were added to serumstarved C2 cells in the presence of N-Shh, and the expression of muscle-specific proteins involved in cell proliferation and differentiation was analyzed after 1 day. Ly294002 abolished the Shh-induced stimulatory effect on all tested proteins-Pax7, MEF2 and MHC (Fig. 8) . However, UO126 administration only slightly inhibited MEF2 and MHC, and had no effect on Pax7 expression levels. Fig. 7 . Shh affects MAPK/ERK and Akt phosphorylation in a manner similar to IGF-I. Serum-starved C2 cells were stimulated with 1 μg/ml Shh, 30 ng/ml HGF or 7.5 ng/ml IGF-I for the indicated times. Cell lysates were resolved by SDS-PAGE and subjected to immunoblotting with anti-phospho-ERK1/2 (A) and anti-phospho-Akt antibodies (B). Parallel membranes were probed with antitotal ERK1/2 and anti-total Akt antibodies. Fig. 8 . Shh effects on muscle cell differentiation are mediated via the PI3K/Akt pathway. Serum-starved C2 cells were treated with or without 1 μg/ml Shh in the presence or absence of UO126 (10 μM) and Ly294002 (25 μM) for 24 h. Myogenic markers for proliferation and differentiation were analyzed by western blot for Pax7, MEF2 and MHC. α-Tubulin bands represent loaded protein quantity. 
Discussion
During early embryogenesis, Shh, secreted from the notochord or neural floor plate, plays a crucial role in the formation and survival of the dorsal myotome muscle-cell lineages [18, 20, 22] . In adults, Shh has been reported to improve muscle cell survival and proliferation; however its role in cell differentiation remains ambiguous [16, 17] . Our studies provide evidence that Shh has a stimulatory effect on the proliferation and differentiation of adult myoblasts. Moreover, Shh expression is found in the position of adult myoblasts in muscle. Its transcript expression is regulated during muscle cell differentiation and during early muscle growth in chicks.
Shh and Ptch1 mRNAs were expressed in myoblasts derived from pectoralis muscles of late-term chick embryos, with an increase in these mRNA levels in adult myoblasts in the days posthatch. Previously, we reported that primary cultures of chicken myoblasts strongly reflect the myogenic activity of satellite cells in the muscle tissue, which peaks at around day 3 posthatch [6, 36] . Indeed, Shh mRNA levels in the pectoralis muscle tissue were markedly upregulated on day 3 posthatch, postulating that most of the Shh in muscle is transcribed in adult myoblasts. We do not exclude the possibility that in addition to adult myoblasts, Shh is also produced and secreted from interstitial cells, as previously reported by Pola et al. [28] . To the best of our knowledge, Shh is not expressed in muscle precursor cells during early embryogenesis. Hence, its expression found in late-term embryos can be attributed to the adult myoblasts, being the majority of the myogenic cell population in the muscle [33] . Moreover, Shh was found to be co-expressed with Pax7 and its expression corresponded to that of Ptch1 and laminin in postnatal mouse muscle sections. Together, these data indicate that Shh is produced and secreted from adult myoblasts to the basal lamina of the myofibers.
Our recent studies on the expression patterns of Pax7 and myogenin in posthatch chicks led us to propose that on day 3 posthatch, some of the adult myoblasts are still proliferating while others are expressing high levels of myogenin, indicating the onset of cell differentiation in the muscle [6, 32] . This process then proceeds until day 8, when cell numbers decline dramatically [36] . Indeed, MyoD mRNA expression levels were still high on day 3 posthatch (Figs. 1A, C) , while those of Shh, Gli and Ptch1 increased, in an expression dynamic consistent with that of Shh and its target genes during differentiation of adult myoblast cultures (Fig. 1B) . Taken together, we suggest that the expression of the Shh cascade is regulated during adult myoblast proliferation and differentiation in muscle in the early growth phase posthatch.
The findings that: (a) Shh is transcribed in primary cultures of adult myoblasts, (b) the increase in Shh gene expression levels precedes that of its target genes, Ptch1 and Gli1, during muscle cell differentiation in culture (Fig. 1B) [27] , (c) addition of NShh induces Ptch1 mRNA and protein expression levels in muscle cells (Fig. 3 ) [17] , and (d) inhibition of Shh signaling decreases the levels of its downstream genes in C2 cells (Fig.  4D) suggest that during the early phases of postnatal muscle growth, Shh acts in an autocrinic manner as either a short-range or long-range molecule [47] [48] [49] . The autocrinic signaling of Shh has been shown in odontogenesis [50] and in the promotion of cancer development [51] . Taken together, these findings imply a different mechanism of action for Shh in postnatal muscle as opposed to embryonic muscle where Shh is secreted from adjacent tissues and plays a role in myogenesis, thereby plays in a paracrinic manner [18] [19] [20] 22] .
In light of the dynamics of Shh expression during muscle growth of posthatch chicks and during muscle cell differentiation, we suggest that Shh specifically affects adult muscle cell proliferation and differentiation. Our view is further supported by direct experiments in primary cultures of chicken cells as well as in a mouse myogenic cell line. In both cell cultures, the expression levels of Pax7, an early proliferation marker [6] , and thymidine incorporation by DNA (data not shown), were stimulated in response to Shh, corroborating previous reports on the stimulatory effect of Shh on muscle cell proliferation [17, 20, 23] . Likewise, Shh increased the expression levels of myogenic regulatory factors, as well as of MHC and cell-cycle proteins involved in muscle cell differentiation [37] [38] [39] [40] . Shhmediated induction of muscle markers was specific, as evidenced by cyclopamine's inhibitory effect. Whereas our results on the effect of Shh on muscle cell differentiation corroborate those published by Duprez et al. [23] and Li et al. [16] , they contradict other reports [17] . It may well be that in the latter studies, the presence of different sera in the cultures affected the cell's response to Shh. Here, as cells were rendered quiescent in serum-free medium, there was no interference of growth factors which could potentially mask the N-Shh effect on cell differentiation. Moreover, we have reported that these cells retain their capacity to return to the cell cycle, indicating that they have not undergone spontaneous terminal differentiation [52, 53] . Taken together, the dynamics of Shh and its downstream genes in adult myoblasts of growing chicks and the stimulatory effect of Shh on muscle differentiation markers (at the mRNA and protein levels in two animal species) strongly suggest its promotive effect on adult myoblast differentiation.
Shh is known to elicit its effects by binding to its receptor Ptch1, thereby releasing Ptch1 inhibitory effect on the effector Smo, which then transduces a signal for activation of Gli family members. Although the mechanism of this signaling pathway has not been fully elucidated, recent reports suggest that the PI3K/Akt pathway is crucial for Shh signaling [43, 44] . In this study, we demonstrate for the first time the promotive effect of Shh on MAPK/ERK and Akt phosphorylation, and its role in regulating these pathways in adult muscle cells. Several lines of evidence support our notion: (a) the regulation of MAPK/ERK and Akt phosphorylation is demonstrated in dose-dependent and time-course experiments in primary cultures of chicken adult myoblasts as well as in mouse C2 cells (Fig. 5) . It is unlikely that Shh's stimulatory effect on these proteins' phosphorylation is due to the nonspecific effects of growth factors present in the medium as the cells were kept under serum-starved conditions for a long period of time. (b) Under the same experimental conditions, neither MAPK/ERK nor Akt phosphorylation was detected in PC3 hepatocytes, known to respond to Shh [46] , suggesting the cell-type specificity of Shh's effects on MAPK [43, 44, 54] . Taken together, we propose that in adult muscle cells, MAPK/ERK and PI3K/Akt cascades are regulated downstream of Shh and are required for its signaling pathway.
In muscle, PI3K/Akt signaling promotes cell survival as well as differentiation and hypertrophy [13, 14] , whereas the MAPK/ ERK signaling pathway is pivotal for cell proliferation [10, 55] . Does Shh transduce its effects on muscle cell proliferation and differentiation via these pathways? Shh's effect on MAPK/ERK phosphorylation was highly transient, particularly in the C2 cells, whereas Akt phosphorylation was high and sustained for as long as 7 h of incubation. In addition, the time course of MAPK/ERK and Akt phosphorylation in response to Shh was more comparable to that of IGF-I, which induces differentiation via the PI3K pathway [12] [13] [14] , than to that of HGF, which induces muscle cell proliferation mainly via the MAPK/ERK pathway [10, 11] . Moreover, we demonstrate that the specific PI3K inhibitor Ly294002, but not the specific MAPK/ERK inhibitor UO126, blocks Shh-mediated induction of musclespecific protein expression. In view of these findings, we suggest that while Shh's effects on cell differentiation are directly mediated via the PI3K/Akt pathway downstream of Smo, MAPK/ERK probably does not mediate the promotive effects of Shh on muscle cell proliferation. It may well be that other effects of Shh (e.g. cell survival) [17, 21] are mediated via the MAPK/ ERK pathway [56, 57] .
Our data support a role for Shh in promoting proliferation and differentiation of adult muscle cells. By inducing its receptor, Ptch1, Shh plays a role in cell proliferation, and by maintaining high levels of Ptch1, Shh stimulates cell differentiation. Both the MAPK/ERK and PI3K/Akt pathways are regulated by Shh and are required for its effects on adult myoblasts. However, it appears that the PI3K/Akt pathway mediates and is essential for Shh-stimulated muscle cell differentiation, and is essential for this process, whereas MAPK/ERK is less important. Collectively, these data shed more light on the mechanism of action of Shh in inducing proliferation and differentiation in postnatal muscle.
